Clinical trial
Vaccine Therapy in Treating Patients With Colorectal Cancer Metastatic to the…
NCT00033748 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00033748 |
|---|---|
| Title | Vaccine Therapy in Treating Patients With Colorectal Cancer Metastatic to the Liver |
| Official title | Sequential Phase II Study of the Anti-Idiotype Monoclonal Antibody Vaccine CeaVac and TriAb in Patients With Minimal Metastatic Colorectal Cancer |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer, Metastatic Cancer |
| Intervention type | Biological |
| Interventions | monoclonal antibody 11D10 anti-idiotype, monoclonal antibody 3H1 Alu Gel |
| Enrollment | 56 |
| Start date | Dec 1, 2001 |
| Primary completion | Mar 1, 2007 |
| Completion | Jun 1, 2010 |
| First posted | Jan 27, 2003 |
| Last update posted | Jul 19, 2016 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: